Editorial Expression of Concern: The bromodomain and extra-terminal inhibitor CPI203 enhances the antiproliferative effects of rapamycin on human neuroendocrine tumors.

IF 12.2 1区生物学 Q1 CELL BIOLOGY

Cell Death & Disease Pub Date : 2026-09-25 DOI:10.1038/s41419-026-09313-9

C Wong, S V Laddha, L Tang, E Vosburgh, A J Levine, E Normant, P Sandy, C R Harris, C S Chan, E Y Xu

引用次数: 0

查看原文本刊更多论文

编辑关注：溴域和末端外抑制剂CPI203增强了雷帕霉素对人类神经内分泌肿瘤的抗增殖作用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cell Death & Disease CELL BIOLOGY-

CiteScore

15.10

自引率

2.20%

发文量

935

审稿时长

2 months

期刊介绍： Brought to readers by the editorial team of Cell Death & Differentiation, Cell Death & Disease is an online peer-reviewed journal specializing in translational cell death research. It covers a wide range of topics in experimental and internal medicine, including cancer, immunity, neuroscience, and now cancer metabolism. Cell Death & Disease seeks to encompass the breadth of translational implications of cell death, and topics of particular concentration will include, but are not limited to, the following: Experimental medicine Cancer Immunity Internal medicine Neuroscience Cancer metabolism